The efficacy of febuxostat or topiroxostat on nephropathy in type 2 diabetes with hyperuricemia: A randomized clinical trial
Not Applicable
- Conditions
- Type 2 diabetes with hyperuricemia
- Registration Number
- JPRN-UMIN000031708
- Lead Sponsor
- Yokohama City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients whose baseline eGFR were <30 ml/min/1.73m^2. 2)Patients treated with uric acid synthesis inhibitors or uricosuric drugs. 3)Patients with severe infections. 4)Patients who are receiving chemotherapy with malignancy. 6)Patients who are judged by an investigator to be inappropriate for this study for any other reason.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method